Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01741259 · ClinicalTrials.gov registry record · NA
A Comparison of Meperidine for Post-Cesarean Analgesia: Bolus Versus Infusion and Bolus
A NA study, sponsored by Mercy Research.
- Completed
- Registry status
- NA
- Development phase
- 273
- Enrollment target
NCT01741259: Completed NA study, sponsored by Mercy Research.
NCT01741259 is a NA study that has completed, run by Mercy Research. The registered enrollment target is 273 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01741259, a NA study, has completed, sponsored by Mercy Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 273 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if epidural meperidine administered by patient-controlled bolus button is equivalent to a low dose infusion plus patient-controlled bolus.
Primary Outcome
Verbal Pain Score on a 0-10 scale is recorded by the nurse at 0, 4, 8, 12, 16, 20, 24, 28, 32, 36,40, 44, and 48 hours after transfer to the post-partum floor. On this scale, 0 represents no pain at all and 10 represents the worst pain imaginable. Because we were relying on nurses to capture this data in the course of normal patient care, scores within 1 hour before or after the goal time were accepted. For each patient, the average of all pain scores was taken and this was considered to be the
Interventions
- DRUG Meperidine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 273 participants |
| Start Date | 2013-08 |
| Est. Completion | 2015-04 |
| Phase | NA |
What the finished NCT01741259 record still lists
NCT01741259 is an interventional study that assigns participants to a tested intervention. The registered 273 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower).
The record links to 0 conditions, and to 1 intervention - of which Meperidine is the first listed.
NCT01741259 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01741259 about?
NCT01741259 is a clinical study titled "A Comparison of Meperidine for Post-Cesarean Analgesia: Bolus Versus Infusion and Bolus". The purpose of this study is to determine if epidural meperidine administered by patient-controlled bolus button is equivalent to a low dose infusion plus patient-controlled bolus.
What is the current status of trial NCT01741259?
This trial is currently completed. It is a NA study. The enrollment target is 273 participants. The study started on 2013-08. Estimated completion is 2015-04.
What interventions are being tested in trial NCT01741259?
The interventions under investigation include: Meperidine (DRUG).
Who is sponsoring clinical trial NCT01741259?
This trial is sponsored by Mercy Research, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01741259's enrollment target sits among peer trials
273 386th of 2000 higher than 1,614 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07229430 · 273 participants · NA
Safety and Effectiveness Evaluation of the High-intensity Focused Ultrasound Device for Lifting Lax Submental and Neck Tissue
- NCT03808922 · 274 participants · Phase 3
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
- NCT04573504 · 274 participants · Phase 4
Antibiotics for Severe Perineal Laceration to Prevent Infection Following Repair
- NCT05289557 · 274 participants · Phase 3
The Efficacy and Safety of Bonjesta® for Nausea and Vomiting of Pregnancy in Pregnant Adolescents
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia